title: Profiling of oxidized phospholipids in lipoproteins from patients with coronary artery disease by hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry.
abstract: Oxidized phospholipids (Ox-PLs) are oxidatively modified PLs that are produced during the oxidation of lipoproteins; oxidation of low density lipoproteins especially is known to be associated with the development of coronary artery disease (CAD). In this study, different lipoprotein classes (high density, low density, and very low density lipoproteins) from pooled plasma of CAD patients and pooled plasma from healthy controls were size-sorted on a semipreparative scale by multiplexed hollow fiber flow field-flow fractionation (MxHF5), and Ox-PLs that were extracted from each lipoprotein fraction were quantified by nanoflow liquid chromatography-tandem mass spectrometry (nLC-ESI-MS/MS). The present study showed that oxidation of lipoproteins occurred throughout all classes of lipoproteins with more Ox-PLs identified from CAD patient lipoproteins: molecular structures of 283 unique PL species (including 123 Ox-PLs) from controls and 315 (including 169 Ox-PLs) from patients were identified by data-dependent collision-induced dissociation experiments. It was shown that oxidation of PLs occurred primarily with hydroxylation of PL; in particular, a saturated acyl chain such as 16:0, 18:0, or even 18:1 at the sn-1 location of the glycerol backbone along with sn-2 acyl chains with at least two double bonds were identified. The acyl chain combinations commonly found for hydroxylated Ox-PLs in the lipoproteins of CAD patients were 16:0/18:2, 16:0/20:4, 18:0/18:2, and 18:0/20:4.
authors.affiliation: Department of Chemistry, Yonsei University , Seoul, 120-749, Korea.
authors.forename: Ju Yong
authors.initials: JY
authors.lastname: Lee
authors.forename: Seul Kee
authors.initials: SK
authors.lastname: Byeon
authors.forename: Myeong Hee
authors.initials: MH
authors.lastname: Moon
mesh_terms: D000328:Adult; D002853:Chromatography, Liquid / Q000379:methods; D003324:Coronary Artery Disease / Q000097:blood* / Q000378:metabolism; D004867:Equipment Design; D031521:Fractionation, Field Flow / Q000295:instrumentation / Q000379:methods; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000737:chemistry* / Q000378:metabolism; D008875:Middle Aged; D010084:Oxidation-Reduction; D010743:Phospholipids / Q000032:analysis* / Q000097:blood* / Q000378:metabolism; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods; D053719:Tandem Mass Spectrometry / Q000379:methods
chemical_list: D008074:Lipoproteins; D010743:Phospholipids